Fondazione Epatocentro Ticino
Clinical trials sponsored by Fondazione Epatocentro Ticino, explained in plain language.
Upcoming readouts
Trials from this sponsor expected to report results within the next 12 months.
- Can a blue dye tame hepatitis b? Results expected May 2027 (estimated)
-
Can a blue dye tame hepatitis b?
Disease control Recruiting nowThis pilot study tests whether methylene blue, a compound with antiviral properties in lab tests, can reduce hepatitis B virus levels in people with chronic infection. Participants take methylene blue capsules for up to 6 months, with the dose possibly increasing if the initial d…
Phase 2 • Sponsor: Fondazione Epatocentro Ticino • Aim: Disease control
Last updated Aug 23, 2026 00:00 UTC
-
Fatty liver disease: a new biobank aims to unlock the secrets of a silent epidemic
Knowledge-focused Recruiting nowThis study creates a large database and biobank of people with nonalcoholic fatty liver disease (NAFLD), a condition where fat builds up in the liver. Researchers will collect medical data and biological samples over time to study how the disease develops, progresses, and respond…
Sponsor: Fondazione Epatocentro Ticino • Aim: Knowledge-focused
Last updated Jul 23, 2026 00:00 UTC